Cerivastatin


w129



General information:


Withdrawn ID: w129
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): C10AA06
Molecular Formula: C26H34FNO5
Molweight: 459.55



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1997
First death: 1998
First withdrawn: 2001
Last withdrawn: 2001
Reference: https://www.ncbi.nlm.nih.gov/pubmed/15582059



Side-effects:

Total reported cases (submitted by medical professionals) with Cerivastatin as primary suspect: 5


Reported final outcomes:
Life-Threatening condition: 1
Hospitalization (initial or prolonged): 1
Disability: 1


Reported side-effects:

Side-effect Case number
MUSCLE SPASMS2
MALAISE1
ARTHRALGIA1
BLOOD DISORDER1
BLOOD PRESSURE DIASTOLIC INCREASED1
CHROMATURIA1
COAGULOPATHY1
CONDITION AGGRAVATED1
HEPATIC FIBROSIS1
HYPERTENSION1
JAUNDICE1
LABORATORY TEST ABNORMAL1
LIVER DISORDER1
UNEVALUABLE EVENT1
MENTAL STATUS CHANGES1
MUSCLE DISORDER1
MUSCULAR WEAKNESS1
ORAL PAIN1
PAIN IN EXTREMITY1
POISONING1
RASH1
RENAL DISORDER1
RHABDOMYOLYSIS1
TOOTH FRACTURE1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P04035 10 3-hydroxy-3-methylglutaryl-coenzyme A reductase HMDH_HUMAN



Toxicity information:

Toxicity class: 4
Toxicity type: muscular
LD50: 416 mg/kg



External links:

ChEBML: CHEMBL1477
DrugBank: DB00439